CATEGORIES

Mental Health

LATEST

TRENDING

EDITORS CHOICE

Smoke, Dip, or Pouch It and Suffer the Horrific Consequences?

Tobacco products have been proven to cause various cancers, but new nicotine-containing products are questionable, too.

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

New Non-Profit Organization Focuses on Early-Stage Sponsored Research and Venture Philanthropy to Advance Human Health and Well-being

Unleash the Happy Hormones: The Surprising Magic of Just 2 Hours a Week to Beat the Blues

NEW RESEARCH SUGGESTS IT TAKES LESS THAN 2 HOURS of exercise per week to boost your mood and reduce depression symptoms.

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.